Safety and Efficacy of SHR4640 Combined with Febuxostat for Primary Hyperuricemia: a Multicenter, Randomized, Double-Blind, Phase II Study.
Therapeutic Advances in Musculoskeletal Disease(2022)
关键词
febuxostat,gout,primary hyperuricemia,SHR4640,URAT-1 inhibitor,XOIs
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要